“…Although optimized to achieve high sensitivity, these NGS technologies require high sequencing depth (>10,000X) and is costly during periodical MRD testing. In consideration of both detection limits and accumulated MRD testing costs, we reviewed other simple, sensitive, and cost-effective technologies, which include peptide nucleic acid (PNA)-based method ( 23 , 29 , 34 , 36 ), locked nucleic acid (LNA)-based method ( 21 , 22 , 25 , 26 , 28 , 31 , 32 ), dual priming oligonucleotide (DPO)-based method ( 20 , 24 , 27 , 30 , 33 , 35 , 37 ), and blocker displacement amplification (BDA) ( 38 ). Except for BDA, the mentioned approaches used modified blocker sequence with outperformed affinity to bind with the complementary sequence other than the sequence with a certain mutation.…”